Mahmoud Gharbavi
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery 5
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 9
- Molecular Medicine top 10%
-
- Nanoplatforms for cancer theranostics 9
- Graphene and Nanomaterials Applications 3
-
- Selenium in Biological Systems 3
-
- RNA Interference and Gene Delivery 6
- Protein Interaction Studies and Fluorescence Analysis 5
- Advanced biosensing and bioanalysis techniques 3
Mahmoud Gharbavi
24 papers receiving 592 citations
Peers
Comparison fields: 5 of 95
- Pharmaceutical Science 164
- Biomaterials 193
- Molecular Medicine 46
- Biomedical Engineering 165
- Nutrition and Dietetics 50
Countries citing papers authored by Mahmoud Gharbavi
This map shows the geographic impact of Mahmoud Gharbavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Gharbavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Gharbavi more than expected).
Fields of papers citing papers by Mahmoud Gharbavi
This network shows the impact of papers produced by Mahmoud Gharbavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Gharbavi. The network helps show where Mahmoud Gharbavi may publish in the future.
Co-authorship network
The 23 scholars most cited alongside Mahmoud Gharbavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 16 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 20 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 15 | |
| 12 | 2022 | 37 | |
| 13 | 2022 | 20 | |
| 14 | 2022 | 13 | |
| 15 | 2020 | 52 | |
| 16 | 2020 | 26 | |
| 17 | 2020 | 34 | |
| 18 | 2020 | 14 | |
| 19 | 2020 | 21 | |
| 20 | 2019 | 41 |
About Mahmoud Gharbavi
Mahmoud Gharbavi is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 25 papers that have together received 605 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (9 papers), RNA Interference and Gene Delivery (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Protein Interaction Studies and Fluorescence Analysis (5 papers), Selenium in Biological Systems (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Graphene and Nanomaterials Applications (3 papers). The work is most often cited by research in Pharmaceutical Science (164 citations), Biomaterials (193 citations) and Molecular Medicine (46 citations). Mahmoud Gharbavi has collaborated with scholars based in Iran, Iraq and Türkiye. Frequent co-authors include Ali Sharafi, Hossein Danafar, Jafar Amani, Behrooz Johari, Navid Mousazadeh, Hamidreza Kheiri Manjili, Hamed Rezaeejam, Hamid Rashidzadeh, Elham Rismani and Hamed Nosrati. Their work appears in journals such as Scientific Reports, International Journal of Pharmaceutics and Journal of Biomedical Materials Research Part A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.